openPR Logo
Press release

The LAG-3-Next Generation Immunotherapy Market Size is projected to reach ~USD 6100 Million by 2035, estimates DelveInsight | MacroGenics, Novartis, Bristol-Myers Squibb, Merck, Immutep, and Others

10-11-2022 11:36 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

LAG-3-Next Generation Immunotherapy Market

LAG-3-Next Generation Immunotherapy Market

DelveInsight's LAG-3-Next Generation Immunotherapy Market report also offers comprehensive insights into LAG-3-Next Generation Immunotherapy market size, trends, emerging therapies, technological innovations, market barriers, market drivers, ongoing LAG-3-Next Generation Immunotherapy clinical trials, key pharmaceutical companies, collaboration in the space, and actively pushing the growth of LAG-3-Next Generation Immunotherapy market size forward in the 7MM [US, EU5(France, Germany, the United Kingdom, Spain, and Italy) and Japan].

To know more about the LAG-3-Next Generation Immunotherapy Market report, click here: https://www.delveinsight.com/report-store/lag-3-next-generation-immunotherapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key facts of the LAG-3-Next Generation Immunotherapy Market Report are:
• According to Delveinsight, the market is anticipated to show positive growth due to the launch of upcoming therapies in the LAG-3 Next Generation target during the forecast period 2022-2035. Moreover, the US will occupy the maximum market share in the overall market size in 2035.
• The market size of LAG-3 in the 7MM is expected to rise from ~USD 588 million in 2025 to reach ~USD 6,092 million by 2035, at a CAGR of 26.3% during the study period.
• According to Delveinsight's analysis, the market is expected to show positive growth due to the launch of potential upcoming therapies in the LAG-3 target during the forecast period (2022-2035).
• Currently, numerous trials are undergoing different indications for the LAG-3 target. Some of the major indications anticipated to show a better outcome by the launch of novel drugs include Breast Cancer, NSCLC, Gastric, Gastroesophageal Junction Cancer, Melanoma, Colorectal Cancer, Head and Neck Cancer, Multiple Myeloma.
• The emerging trend in LAG3 Next-generation Immunotherapies with continuous headway movement along with new emerging technologies for the development of targeted therapies augurs the hopes for better therapeutic alternatives.

Request for Free Sample Report to know in detail about LAG-3-Next Generation Immunotherapy market report facts and latest updates: https://www.delveinsight.com/sample-request/lag-3-next-generation-immunotherapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of LAG-3-Next Generation Immunotherapy Companies are:
• MacroGenics
• Novartis
• Bristol-Myers Squibb
• Merck
• Immutep
• Regeneron
• Xencor
• Incyte Biosciences
• Agenus
• F-star Therapeutics
• And Many Others

Click here to know more about the companies working in the LAG-3-Next Generation Immunotherapy treatment market: https://www.delveinsight.com/sample-request/lag-3-next-generation-immunotherapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cancer immunotherapy and tumor microenvironment have been at the forefront of research over the past decades. Targeting immune checkpoints, especially programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1), has made a breakthrough in treating advanced malignancies. However, the low response rate brings a daunting challenge, changing the focus to dig deeply into the tumor microenvironment for alternative therapeutic targets. Strikingly, the inhibitory immune checkpoint Lymphocyte Activation Gene-3 (LAG-3) holds considerable potential.
LAG-3 suppresses T-cells activation and cytokine secretion, thereby ensuring immune homeostasis. It exerts differential inhibitory impacts on various types of lymphocytes and shows a remarkable synergy with PD-1 to inhibit immune responses. Targeting LAG-3 immunotherapy is moving forward in active clinical trials, and combination immunotherapy of anti-LAG-3 and anti-PD-1 has shown exciting efficacy in fighting PD-1 resistance.

Some of LAG-3-Next Generation Immunotherapy Drugs are:
• MGD013
• LAG525
• Relatlimab
• MK-4280
• Eftilagimod Alpha
• INCAGN2385
• FS118
• REGN3767
• XmAb22841
• And Many Others

To know more about the recent updates regarding the LAG-3-Next Generation Immunotherapy and drugs: https://www.delveinsight.com/sample-request/lag-3-next-generation-immunotherapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the LAG-3-Next Generation Immunotherapy Market Insight Report
• Geography Covered: The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• Study Period: 3-year historical and 10-year forecasted analysis (2020-2035).
• Key LAG-3-Next Generation Immunotherapy Companies: MacroGenics, Novartis, Bristol-Myers Squibb, Merck, Immutep, Regeneron, Xencor, and others.
• Case Studies
• KOL's Views
• Analyst's View

Learn more about the report offerings @ LAG-3-Next Generation Immunotherapy Market Outlook: https://www.delveinsight.com/sample-request/lag-3-next-generation-immunotherapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com

About Delveinsight:
DelveInsight Business Research is a leading Market Research and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The LAG-3-Next Generation Immunotherapy Market Size is projected to reach ~USD 6100 Million by 2035, estimates DelveInsight | MacroGenics, Novartis, Bristol-Myers Squibb, Merck, Immutep, and Others here

News-ID: 2763471 • Views:

More Releases from DelveInsight Business Research

Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Companies
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, DelveInsight Finds
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics. DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,

All 5 Releases


More Releases for Generation

Digital Services for Lead Generation | Local Lead Generation Websites | Lead Gen …
Lead Generation consists of attracting and renovating target audiences that have shown interest in your product or services. The objective is to guide prospects through the purchaser’s journey to the end of the sales funnel. Content is one of the leading tools B2B marketers utilize to create leads. This may comprise of social media posts, blog posts, coupons and live events. You utilize the forms to capture leads that employ
Digital Services for Lead Generation, Local Lead Generation Websites
Businesses these days are reliant on lead generation to advertise their service before the consumers to get more business and endure in bullish market. The Lead generation service is an unceasing effort to attract and change the target audience’s mind towards the business offering. It is an act of completely compelling the consumer to purchase the business services. It will boost brand image and outcome in good sales for the
Digital Services for Lead Generation, Lead Generation Platforms: Ken Research
The Lead generation is the practice of gaining fresh leads for your business. It is cultivating the interest of a person in your product or service so much that they distribute you with their contact specifics. It is the start of the technique which leads to a prospective customer turning into a purchaser. And then perchance buying from your business. Your business should then be nurturing such leads that you
Digital Services for Lead Generation | Lead Generation Platforms: Ken Research
There are several channels and marketing tools for the digital marketers to utilize to get customers to notice their brand. If your business functions appropriate when in direct communication with the customers over the phone, the lead generation marketing can provide a number of benefits. The lead generation marketing is about motivating the interest of customers in a product or service and capturing that interest by obtaining those customers to
Local Lead Generation Websites | Best Companies for Online Lead Generation | Lea …
The Lead Generation is a foremost marketing procedure that comprise finding people who would be interested in purchasing your product and/or services. It comprises collecting contact details of the interested impending buyers/consumers in exchange for something that is of worth to them - for e.g educational, collateral, research content or a free trial of a product. This is a foremost activity to build a sales pipeline. The Lead Generation is
lead generation company | Best Lead Generation Company in India | Online Lead Ge …
Lead Generation: The Lead generation firms supply your corporate with the hot leads you necessary to acquire fresh clients, while releasing up your time to spend on other responsibilities, like product improvement or quality declaration. Contrariwise, you could double down on fresh leads, hammering up business in tandem with leads delivered by the generation firms. The Business enlargement is openly correlated with finding fresh clients and making them happy, and